Capture.JPG
Nucleome Therapeutics appoints Dr Stephen Harrison as Chief Scientific Officer
November 13, 2023 03:00 ET | Nucleome Therapeutics
Nucleome Therapeutics appoints Dr Stephen Harrison as Chief Scientific Officer Key appointment bringing 30 years of drug discovery and development expertise as the Company continues to build a...
Capture.JPG
Nucleome Therapeutics appoints Dr Russell Greig as Non-Executive Chair of the Board
September 06, 2023 03:00 ET | Nucleome Therapeutics
Nucleome Therapeutics appoints Dr Russell Greig as Non-Executive Chair of the Board Dr Greig brings more than 40 years of experience in the biopharmaceutical sectorExperienced Chair who has led...
Nucleome Therapeutics logo.JPG
Nucleome Therapeutics announces publication of a novel method enabling 3D genome mapping at single base pair resolution in the journal Nature
June 10, 2021 02:00 ET | Nucleome Therapeutics
Nucleome Therapeutics announces publication of a novel method enabling 3D genome mapping at single base pair resolution in the journal Nature New method is being used by Nucleome to unlock the...